We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.79B
AUM Growth
+$579M
Cap. Flow
+$109M
Cap. Flow %
1.4%
Top 10 Hldgs %
71.8%
Holding
138
New
7
Increased
44
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$349M
2
PG icon
Procter & Gamble
PG
+$148M
3
KO icon
Coca-Cola
KO
+$22.7M
4
HDB icon
HDFC Bank
HDB
+$9.79M
5
PFE icon
Pfizer
PFE
+$5.65M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$216M
2
C icon
Citigroup
C
+$118M
3
V icon
Visa
V
+$63.9M
4
DXCM icon
DexCom
DXCM
+$5.47M
5
KTWO
K2M Group Holdings, Inc
KTWO
+$5.35M

Sector Composition

Rank Sector Weight
1 Financials 26.45%
2 Consumer Discretionary 18.43%
3 Healthcare 14.45%
4 Communication Services 13.53%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$322B
$23.4M 0.3%
345,793
– –
AMGN icon
27
Amgen
AMGN
$208B
$22.9M 0.29%
110,716
– –
BIIB icon
28
Biogen
BIIB
$30B
$20.9M 0.27%
59,070
+10,484
+22% +$3.61M
GILD icon
29
Gilead Sciences
GILD
$162B
$16.5M 0.21%
213,104
-32,879
-13% -$2.48M
EW icon
30
Edwards Lifesciences
EW
$49.6B
$16.1M 0.21%
277,179
– –
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$14.5M 0.19%
75,343
+10,813
+17% +$1.93M
AGN
32
DELISTED
Allergan plc
AGN
$14.5M 0.19%
75,890
-9,211
-11% -$1.69M
SHPG
33
DELISTED
Shire pic
SHPG
$14.3M 0.18%
78,678
– –
BSX icon
34
Boston Scientific
BSX
$69.5B
$14.1M 0.18%
367,194
– –
BDX icon
35
Becton Dickinson
BDX
$45.6B
$13.8M 0.18%
54,279
– –
CNC icon
36
Centene
CNC
$30.7B
$13.6M 0.17%
187,306
– –
HCA icon
37
HCA Healthcare
HCA
$87.2B
$12.9M 0.17%
92,727
+13,192
+17% +$1.64M
ABBV icon
38
AbbVie
ABBV
$443B
$11.9M 0.15%
125,780
-17,491
-12% -$1.66M
CELG
39
DELISTED
Celgene Corp
CELG
$11.3M 0.15%
126,797
+3,727
+3% +$329K
AMRN
40
Amarin Corp
AMRN
$299M
$11.1M 0.14%
+34,000
New +$2.57M
LLY icon
41
Eli Lilly
LLY
$1.02T
$9.86M 0.13%
91,848
– –
ESRX
42
DELISTED
Express Scripts Holding Company
ESRX
$9.59M 0.12%
100,939
-18,665
-16% -$1.59M
VTRS icon
43
Viatris
VTRS
$20.4B
$9.42M 0.12%
257,473
-73,195
-22% -$2.75M
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
$9.15M 0.12%
65,847
-9,727
-13% -$1.22M
NVCR icon
45
NovoCure
NVCR
$1.73B
$8.64M 0.11%
164,953
-48,200
-23% -$1.92M
JAZZ icon
46
Jazz Pharmaceuticals
JAZZ
$15.9B
$8.4M 0.11%
49,935
+343
+0.7% +$59K
CI icon
47
Cigna
CI
$73.7B
$7.65M 0.1%
36,723
– –
SRPT icon
48
Sarepta Therapeutics
SRPT
$1.57B
$7.6M 0.1%
47,046
-22,381
-32% -$3.06M
BMY icon
49
Bristol-Myers Squibb
BMY
$133B
$7.46M 0.1%
120,199
– –
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$11.6B
$7.32M 0.09%
75,431
+18,919
+33% +$1.89M
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

C WorldWide Group's Q3 2018 Portfolio in Review

As of Q3 2018, C WorldWide Group held 138 positions worth $7.79B, up 8% from $7.21B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

C WorldWide Group's Q3 2018 filing shows 7 new, 44 increased, 52 reduced and 7 closed positions. Its largest new stake was ExxonMobil: 4,273,004 shares worth $363M. The largest sale was Philip Morris, an estimated $216M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q3 2018 buy was ExxonMobil: 4,273,004 shares worth $363M.
  • C WorldWide Group added most to Procter & Gamble in Q3 2018, an estimated $148M increase.
  • C WorldWide Group's biggest Q3 2018 reduction was Citigroup, cutting an estimated $118M.
  • C WorldWide Group fully exited Philip Morris in Q3 2018, selling an estimated $216M.
  • C WorldWide Group's ten largest holdings make up 72% of its $7.79B portfolio in Q3 2018.
  • C WorldWide Group opened 7 new positions and closed 7 in Q3 2018.
  • C WorldWide Group's portfolio value rose 8% quarter-over-quarter to $7.79B.

Based on C WorldWide Group's 13F filing for Q3 2018, filed 5 Nov 2018.